NCT00553800 - Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 5, 2007

Primary Completion Date

January 12, 2011

Study Completion Date

June 1, 2011

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG

bevacizumab

DRUG

Erlotinib

Trial Locations (7)

Grand View Hospital, Sellersville

Abramson Cnacer Center, University of Pennsylvania, Philadelphia

Pennsylvania Oncology Hematology Associates, Philadelphia

Fox Chase Cancer Center, Philadelphia

Paoli Hospital, Paoli

AtlantiCare Regional Medical Center, Galloway

Fox Chase Virtua Health Cancer Program at Memorial, Mount Holly